Phase 1 biotech developing FXR agonist therapies for NASH.
Industry: Health Care
First Day Return: -9.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 08/24/2020 |
Offer Price | $13.00 |
Price Range $12.00 - $14.00 | |
Offer Shares (mm) | 6.5 |
Deal Size ($mm) | $85 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/15/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $85 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | San Diego, CA, United States |
Founded | 2014 |
Employees at IPO | 32 |
Website www.metacrine.com |